New sheep placenta therapy used to banish wrinkles

By Admin
A Harley Street doctor has developed an unusual new cosmetic surgery treatment which is being branded as an ‘alternative facelift. Rather than ut...

A Harley Street doctor has developed an unusual new cosmetic surgery treatment which is being branded as an ‘alternative facelift’.

Rather than utilising a cream or Botox injections, sheep placenta is the main ingredient in the new Actistem treatment, which apparently acts as a cure for wrinkles.

It is thought that sheep placenta contains a protein which, when it comes into contact with skin, can help to stimulate collagen production.

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of Healthcare Global, click here

According to Dr Roberto Veil, the brains behind the treatment, the placenta is full of stem cells which replenishes the skin and encourages the production of collagen and elastin, resulting in a skin firming effect.

Patients who undergo the Actistem procedure have an anaesthetic cream applied to their face, which is followed by a dermaroller treatment to stimulate the blood flow in the skin.

This is followed by the application of the sheep placenta, a clear, thick, liquid, which is massaged into the face.

Dr Weil repeats the process three times as part of one treatment and after three days patients will notice an improvement in skin texture.

After two weeks the elastin and collagen count in the skin increases and it will be lifted and tightened, reducing the appearance of wrinkles.

The sheep placenta is imported to Dr Veil’s London Centre for Aesthetic Surgery from Australia and the Actistem treatments take 30 mintues, cost £600 and results can last up to five months. 

Share

Featured Articles

UnitedHealth CEO Admits Hack hit Third of US Citizens' Data

UnitedHealth Group CEO Andrew Witty tells stunned US congressional hearing Change Healthcare cyberattack affects third of the US population

Why Sanofi Leads the way on Healthcare Sustainability

How French multinational Sanofi is ensuring delivery of essential medical supplies while being ESG-compliant

Philips Q1 Results hit by $1.1bn Respironics Settlement

As Royal Philips reports Q1 2024 results we profile the Netherlands-based healthcare technology company, who made the switch from consumer electronics

Vaccine Breakthrough on Antibiotics Resistant Diseases

Medical Devices & Pharma

Oracle Fusion Cloud Update Boost for Patients

Technology & AI

WHO Tightens air Quality Guidelines as Pollution Kills 7mn

Sustainability